{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:51:17Z","timestamp":1791507077894,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":91,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Early diagnosis of Alzheimer\u2019s disease (AD), especially accurate identification at the mild cognitive impairment (MCI) stage, is crucial for slowing disease progression. Although deep learning has achieved promising performance in AD diagnosis, existing multimodal models often operate as \u201cblack boxes,\u201d lacking the transparency required for clinical practice and failing to explicitly model deep interactions between imaging and clinical features. To address these limitations, this study proposes an interpretable multimodal framework, namely the Compact Biomarker Kolmogorov\u2013Arnold Network (CBKAN). Specifically, we introduce EHCTNet with disease-specific attention to extract features from 3D MRI data, and innovatively constrain the encoder to output a set of compact biomarkers instead of traditional high-dimensional abstract vectors, mimicking the diagnostic logic of clinicians (e.g., judging brain atrophy). In addition, a hybrid feature Transformer is used to fuse these imaging biomarkers with clinical and genetic data, explicitly capturing complementary relationships across modalities. Finally, the Kolmogorov\u2013Arnold Network (KAN) is adopted as the classifier to effectively model the highly nonlinear characteristics of AD progression. Experiments on 800 subjects from the ADNI dataset show that CBKAN achieves 91.1% accuracy and an F1-score of 0.910 in the AD\/MCI\/CN classification task, significantly outperforming existing mainstream methods. Statistical analyses validate the effectiveness of each component of the model. The proposed model provides a potentially interpretable and high-performing decision-support framework for early Alzheimer\u2019s disease diagnosis, although its cross-cohort generalizability and real-world clinical utility require further validation in independent external datasets.<\/jats:p>","DOI":"10.1038\/s41598-026-59430-w","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T07:44:30Z","timestamp":1783669470000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An interpretable multimodal framework using compact biomarkers and Kolmogorov\u2013Arnold networks improves the early diagnosis of Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Daiqing","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LianYing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiqing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"issue":"5","key":"59430_CR1","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.jalz.2011.05.2410","volume":"7","author":"CG Lyketsos","year":"2011","unstructured":"Lyketsos, C. G. et al. Neuropsychiatric symptoms in Alzheimer\u2019s disease. Alzheimers Dement. 7(5), 532\u2013539 (2011).","journal-title":"Alzheimers Dement."},{"key":"59430_CR2","unstructured":"Chen, S. Y., Lin, Z. C., Ying, J. Q., Li, W. Y., Liu, Z. T., Fang, T. Y., & Li, L. P. Apolipoprotein E and Alzheimer\u2019sDisease: Risk, Mechanisms, and Treatment. Progress in Biochemistry and Biophysics, 52(3), 569\u2013591. (2025)."},{"key":"59430_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.709156","volume":"13","author":"Y Gao","year":"2021","unstructured":"Gao, Y. & Liu, X. Secular trends in the incidence of and mortality due to Alzheimer\u2019s disease and other forms of dementia in China from 1990 to 2019: An age-period-cohort study and joinpoint analysis. Front. Aging Neurosci. 13, 709156 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"59430_CR4","unstructured":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 7(2), e105\u2013e125 (2022)."},{"issue":"1","key":"59430_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S1474-4422(19)30290-X","volume":"19","author":"L Jia","year":"2020","unstructured":"Jia, L. et al. Dementia in China: Epidemiology, clinical management, and research advances. Lancet Neurol. 19(1), 81\u201392 (2020).","journal-title":"Lancet Neurol."},{"issue":"1","key":"59430_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jalz.2018.06.3063","volume":"15","author":"KA Matthews","year":"2019","unstructured":"Matthews, K. A. et al. Racial and ethnic estimates of Alzheimer\u2019s disease and related dementias in the United States (2015\u20132060) in adults aged\u2265 65 years. Alzheimers Dement. 15(1), 17\u201324 (2019).","journal-title":"Alzheimers Dement."},{"key":"59430_CR7","unstructured":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017, 390(10100), 1211\u20131259."},{"issue":"3","key":"59430_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1001\/archneur.58.3.397","volume":"58","author":"JC Morris","year":"2001","unstructured":"Morris, J. C. et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch. Neurol. 58(3), 397\u2013405 (2001).","journal-title":"Arch. Neurol."},{"issue":"3","key":"59430_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","volume":"256","author":"RC Petersen","year":"2004","unstructured":"Petersen, R. C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 256(3), 183\u2013194 (2004).","journal-title":"J. Intern. Med."},{"issue":"3","key":"59430_CR10","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling, R. A. et al. Toward defining the preclinical stages of Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 7(3), 280\u2013292 (2011).","journal-title":"Alzheimers Dement."},{"issue":"7","key":"59430_CR11","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann, G. et al. Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 34(7), 939\u2013944 (1984).","journal-title":"Neurology"},{"issue":"8","key":"59430_CR12","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","volume":"6","author":"B Dubois","year":"2007","unstructured":"Dubois, B. et al. Research criteria for the diagnosis of Alzheimer\u2019s disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol. 6(8), 734\u2013746 (2007).","journal-title":"Lancet Neurol."},{"issue":"7","key":"59430_CR13","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1001\/archneurol.2010.136","volume":"67","author":"C Reitz","year":"2010","unstructured":"Reitz, C. et al. A summary risk score for the prediction of Alzheimer disease in elderly persons. Arch. Neurol. 67(7), 835\u2013841 (2010).","journal-title":"Arch. Neurol."},{"issue":"9","key":"59430_CR14","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1474-4422(11)70072-2","volume":"10","author":"DE Barnes","year":"2011","unstructured":"Barnes, D. E. & Yaffe, K. The projected effect of risk factor reduction on Alzheimer\u2019s disease prevalence. Lancet Neurol. 10(9), 819\u2013828 (2011).","journal-title":"Lancet Neurol."},{"issue":"4","key":"59430_CR15","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.bcp.2013.12.024","volume":"88","author":"C Reitz","year":"2014","unstructured":"Reitz, C. & Mayeux, R. Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem. Pharmacol. 88(4), 640\u2013651 (2014).","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"59430_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","volume":"6","author":"GB Frisoni","year":"2010","unstructured":"Frisoni, G. B., Fox, N. C., Jack, C. R. Jr., Scheltens, P. & Thompson, P. M. The clinical use of structural MRI in Alzheimer disease. Nat. Rev. Neurol. 6(2), 67\u201377 (2010).","journal-title":"Nat. Rev. Neurol."},{"key":"59430_CR17","volume":"1","author":"N Smailagic","year":"2015","unstructured":"Smailagic, N. et al. 18F-FDG PET for the early diagnosis of Alzheimer\u2019s disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst. Rev. 1, Cd010632 (2015).","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"59430_CR18","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1016\/j.jalz.2013.05.1769","volume":"9","author":"MW Weiner","year":"2013","unstructured":"Weiner, M. W. et al. The Alzheimer\u2019s Disease Neuroimaging Initiative: A review of papers published since its inception. Alzheimers Dement. 9(5), e111-194 (2013).","journal-title":"Alzheimers Dement."},{"key":"59430_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.70041","volume":"17","author":"J Chua","year":"2025","unstructured":"Chua, J. et al. Utilizing deep learning to predict Alzheimer\u2019s disease and mild cognitive impairment with optical coherence tomography. Alzheimer\u2019s & Dement. 17, e70041. https:\/\/doi.org\/10.1002\/dad2.70041 (2025).","journal-title":"Alzheimer\u2019s & Dement."},{"key":"59430_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00530-026-02229-6","volume":"32","author":"I Shahzad","year":"2026","unstructured":"Shahzad, I., Ouyang, J. & Khan, S. U. R. FedVC-ADDiM: A federated learning framework for diagnosis of Alzheimer disease using deep learning. Multimedia Syst. 32, 161. https:\/\/doi.org\/10.1007\/s00530-026-02229-6 (2026).","journal-title":"Multimedia Syst."},{"key":"59430_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-32793-2","volume":"16","author":"B Priyadarshini","year":"2026","unstructured":"Priyadarshini, B. & Alex, J. S. R. A causal deep learning approach to identifying metabolic signatures of cognitive and functional decline in Alzheimer\u2019s disease. Sci. Rep. 16, 2947. https:\/\/doi.org\/10.1038\/s41598-025-32793-2 (2026).","journal-title":"Sci. Rep."},{"key":"59430_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-025-12251-3","author":"Z Chen","year":"2026","unstructured":"Chen, Z. et al. MRI-to-PET synthesis via deep learning for amyloid-\u03b2 quantification in Alzheimer\u2019s disease. Eur. Radiol. https:\/\/doi.org\/10.1007\/s00330-025-12251-3 (2026).","journal-title":"Eur. Radiol."},{"issue":"6","key":"59430_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci15060612","volume":"15","author":"A Muhammad","year":"2025","unstructured":"Muhammad, A., Jin, Q., Elwasila, O. & Gulzar, Y. Hybrid deep learning architecture with adaptive feature fusion for multi-stage Alzheimer\u2019s disease classification. Brain Sci. 15(6), 612. https:\/\/doi.org\/10.3390\/brainsci15060612 (2025).","journal-title":"Brain Sci."},{"issue":"1","key":"59430_CR24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.32996\/jbms.2025.7.1.8","volume":"7","author":"M Sarkar","year":"2025","unstructured":"Sarkar, M. Integrating machine learning and deep learning techniques for advanced Alzheimer\u2019s disease detection through gait analysis. J. Bus. Manag. Stud. 7(1), 140\u2013147. https:\/\/doi.org\/10.32996\/jbms.2025.7.1.8 (2025).","journal-title":"J. Bus. Manag. Stud."},{"key":"#cr-split#-59430_CR25.1","doi-asserted-by":"crossref","unstructured":"Wang, S., Shen, Y., Chen, W., Xiao, T. & Hu, J. Automatic recognition of mild cognitive impairment from MRI images using expedited convolutional neural networks. Artificial Neural Networks and Machine Learning-ICANN 2017: 26th International Conference on Artificial Neural Networks, Alghero, Italy, 2017, Proceedings, Part I 26","DOI":"10.1007\/978-3-319-68600-4_43"},{"key":"#cr-split#-59430_CR25.2","unstructured":"2017: 373-380 (Springer, 2017)."},{"issue":"4","key":"59430_CR26","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1109\/TMI.2019.2937271","volume":"39","author":"L Sun","year":"2019","unstructured":"Sun, L. et al. A 3D spatially weighted network for segmentation of brain tissue from MRI. IEEE Trans. Med. Imaging 39(4), 898\u2013909 (2019).","journal-title":"IEEE Trans. Med. Imaging"},{"key":"59430_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.compmedimag.2018.09.009","volume":"70","author":"F Li","year":"2018","unstructured":"Li, F., Liu, M., Initiative AsDN. Alzheimer\u2019s disease diagnosis based on multiple cluster dense convolutional networks. Comput. Med. Imaging Graph. 70, 101\u2013110 (2018).","journal-title":"Comput. Med. Imaging Graph."},{"issue":"4","key":"59430_CR28","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1109\/TPAMI.2018.2889096","volume":"42","author":"C Lian","year":"2018","unstructured":"Lian, C., Liu, M., Zhang, J. & Shen, D. Hierarchical fully convolutional network for joint atrophy localization and Alzheimer\u2019s disease diagnosis using structural MRI. IEEE Trans. Pattern Anal. Mach. Intell. 42(4), 880\u2013893 (2018).","journal-title":"IEEE Trans. Pattern Anal. Mach. Intell."},{"issue":"5","key":"59430_CR29","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1109\/TBME.2018.2869989","volume":"66","author":"M Liu","year":"2018","unstructured":"Liu, M., Zhang, J., Adeli, E. & Shen, D. Joint classification and regression via deep multi-task multi-channel learning for Alzheimer\u2019s disease diagnosis. IEEE Trans. Biomed. Eng. 66(5), 1195\u20131206 (2018).","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"59430_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.media.2017.10.005","volume":"43","author":"M Liu","year":"2018","unstructured":"Liu, M., Zhang, J., Adeli, E. & Shen, D. Landmark-based deep multi-instance learning for brain disease diagnosis. Med. Image Anal. 43, 157\u2013168 (2018).","journal-title":"Med. Image Anal."},{"key":"59430_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00777","volume":"12","author":"W Lin","year":"2018","unstructured":"Lin, W. et al. Convolutional neural networks-based MRI image analysis for the Alzheimer\u2019s disease prediction from mild cognitive impairment. Front. Neurosci. 12, 777 (2018).","journal-title":"Front. Neurosci."},{"key":"59430_CR32","doi-asserted-by":"crossref","unstructured":"Korolev, S., Safiullin, A., Belyaev, M. & Dodonova, Y. Residual and plain convolutional neural networks for 3D brain MRI classification. In 2017 IEEE 14th International Symposium on Biomedical Imaging (ISBI 2017) 835\u2013838 (IEEE, 2017).","DOI":"10.1109\/ISBI.2017.7950647"},{"issue":"6","key":"59430_CR33","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1109\/JBHI.2023.3257081","volume":"27","author":"H Guan","year":"2023","unstructured":"Guan, H. et al. Attention-guided autoencoder for automated progression prediction of subjective cognitive decline with structural MRI. IEEE J. Biomed. Health Inform. 27(6), 2980\u20132989 (2023).","journal-title":"IEEE J. Biomed. Health Inform."},{"key":"59430_CR34","unstructured":"Liu, W., Fan, S., & Weng, G. (2025). Multi-modal deep learning framework for early Alzheimer\u2019s disease detection using MRI neuroimaging and clinical data fusion. Ann. Appl. Sci. 6(1). Retrieved from https:\/\/annalsofappliedsciences.com\/index.php\/aas\/article\/view\/34."},{"issue":"6","key":"59430_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15060717","volume":"15","author":"S Muksimova","year":"2025","unstructured":"Muksimova, S., Umirzakova, S., Baltayev, J. & Cho, Y. I. Multi-modal fusion and longitudinal analysis for Alzheimer\u2019s disease classification using deep learning. Diagnostics 15(6), 717. https:\/\/doi.org\/10.3390\/diagnostics15060717 (2025).","journal-title":"Diagnostics"},{"key":"59430_CR36","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.neuroscience.2025.04.035","volume":"576","author":"R Zhang","year":"2025","unstructured":"Zhang, R., Sheng, J., Zhang, Q., Wang, J. & Wang, B. A review of multimodal fusion-based deep learning for Alzheimer\u2019s disease. Neuroscience 576, 80\u201395. https:\/\/doi.org\/10.1016\/j.neuroscience.2025.04.035 (2025).","journal-title":"Neuroscience"},{"issue":"4","key":"59430_CR37","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3390\/diagnostics13040801","volume":"13","author":"N Raza","year":"2023","unstructured":"Raza, N., Naseer, A., Tamoor, M. & Zafar, K. Alzheimer disease classification through transfer learning approach. Diagnostics 13(4), 801 (2023).","journal-title":"Diagnostics"},{"key":"59430_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.108979","volume":"180","author":"Q Yu","year":"2024","unstructured":"Yu, Q. et al. A transformer-based unified multimodal framework for Alzheimer\u2019s disease assessment. Comput. Biol. Med. 180, 108979 (2024).","journal-title":"Comput. Biol. Med."},{"issue":"1","key":"59430_CR39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12938-024-01204-4","volume":"23","author":"Y Tang","year":"2024","unstructured":"Tang, Y., Xiong, X., Tong, G., Yang, Y. & Zhang, H. Multimodal diagnosis model of Alzheimer\u2019s disease based on improved Transformer. Biomed. Eng. Online 23(1), 8 (2024).","journal-title":"Biomed. Eng. Online"},{"issue":"1","key":"59430_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31037-5","volume":"13","author":"S Qiu","year":"2022","unstructured":"Qiu, S. et al. Multimodal deep learning for Alzheimer\u2019s disease dementia assessment. Nat. Commun. 13(1), 3404 (2022).","journal-title":"Nat. Commun."},{"issue":"1","key":"59430_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11571-025-10330-1","volume":"19","author":"A Nivethitha","year":"2025","unstructured":"Nivethitha, A. & Manigandan, T. A hybrid deep learning architectures and feature extraction techniques for Alzheimer disease recognition. Cogn. Neurodyn. 19(1), 1\u201314 (2025).","journal-title":"Cogn. Neurodyn."},{"key":"59430_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.neunet.2025.108245","author":"X Kui","year":"2025","unstructured":"Kui, X. et al. Alzheimer\u2019s disease classification based on multimodal consistent distribution and trusted fusion. Neural Netw. https:\/\/doi.org\/10.1016\/j.neunet.2025.108245 (2025).","journal-title":"Neural Netw."},{"key":"59430_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1626922","volume":"16","author":"G Wang","year":"2025","unstructured":"Wang, G. et al. PlgFormer: Parallel extraction of local-global features for AD diagnosis on sMRI using a unified CNN-transformer architecture. Front. Neurol. 16, 1626922 (2025).","journal-title":"Front. Neurol."},{"key":"59430_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.compmedimag.2025.102529","volume":"123","author":"A Francesconi","year":"2025","unstructured":"Francesconi, A. et al. Class balancing diversity multimodal ensemble for Alzheimer\u2019s disease diagnosis and early detection. Comput. Med. Imaging Graph. 123, 102529 (2025).","journal-title":"Comput. Med. Imaging Graph."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59430-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59430-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59430-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:30:53Z","timestamp":1791505853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59430-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["59430"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-59430-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"31656"}}